Switching from azathioprine to mycophenolate mofetil (MMF) improves renal function in paediatric patients with chronic rejection following renal transplantation

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1255, 2000-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate mofetil: Leucopenia, leading to renal transplant rejection: case report

By  

Reactions Weekly, Vol. 1, Iss. 1380, 2011-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

A mycophenolate mofetil (MMF)-based regimen produces good allograft and patient survival rates in elderly recipients of cadaveric renal transplants

By  

Inpharma, Vol. 1, Iss. 1500, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Tacrolimus + sirolimus or MMF in renal transplantation

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Ciclosporin/mycophenolate mofetil: Renal transplant rejection and herpes zoster infection in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Ciclosporin/mycophenolate mofetil/prednisolone: Transitional cell carcinoma of the bladder in a paediatric renal transplant recipient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1338, 2011-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite